These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10999627)

  • 1. Fast quantitation of recombinant plasminogen activator inhibitor type 1 in bacterial lysates by micropellicular reversed-phase liquid chromatography.
    O'Keefe DO; Duke GJ
    J Chromatogr A; 2000 Sep; 891(1):85-92. PubMed ID: 10999627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay for recombinant hepatitis B surface antigen using reversed-phase high-performance liquid chromatography.
    O'Keefe DO; Paiva AM
    Anal Biochem; 1995 Sep; 230(1):48-54. PubMed ID: 8585629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of recombinant rat plasminogen activator inhibitor-1 and development of immunological tools for its quantitation.
    Ngo TH; Verheyen S; Knockaert I; Declerck PJ
    J Pharm Belg; 1997; 52(4):165-6. PubMed ID: 9316343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversed-phase high-performance liquid chromatography assay for recombinant acidic fibroblast growth factor in E. coli cell suspensions and lysate samples.
    DePhillips P; Buckland B; Gbewonyo K; Yamazaki S; Sitrin R
    J Chromatogr A; 1994 Mar; 663(1):43-51. PubMed ID: 7514066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1.
    Ngo TH; Declerck PJ
    Thromb Haemost; 1999 Nov; 82(5):1510-5. PubMed ID: 10595646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of recombinant human interleukin-11 fusion protein derived from Escherichia coli lysate by combined size-exclusion and reversed-phase liquid chromatography.
    Amari JV; Mazsaroff I
    J Chromatogr A; 1996 Apr; 729(1-2):113-24. PubMed ID: 9004932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid reversed-phase high-performance liquid chromatography method for quantitation, at high pH, of the recombinant apolipoprotein A-IMilano in Escherichia coli fermentation broth.
    Mulugeta E; Carnö S; Becker S; Hagman A; Mascher E
    J Chromatogr A; 1998 Mar; 798(1-2):83-90. PubMed ID: 9542129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-step purification of a recombinant protein from a whole cell extract by reversed-phase high-performance liquid chromatography.
    Mills JB; Mant CT; Hodges RS
    J Chromatogr A; 2006 Nov; 1133(1-2):248-53. PubMed ID: 16945380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli.
    Seetharam R; Dwivedi AM; Duke JL; Hayman AC; Walton HL; Huckins NR; Kamerkar SM; Corman JI; Woodeshick RW; Wilk RR
    Biochemistry; 1992 Oct; 31(41):9877-82. PubMed ID: 1382596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples.
    Leng HM; Brouwers E; Knockaert I; Declerck PJ
    Thromb Haemost; 2000 Dec; 84(6):1082-6. PubMed ID: 11154117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples.
    Ngo TH; Verheyen S; Knockaert I; Declerck PJ
    Thromb Haemost; 1998 Apr; 79(4):808-12. PubMed ID: 9569197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile quantitation of free thiols in a recombinant monoclonal antibody by reversed-phase high performance liquid chromatography with hydrophobicity-tailored thiol derivatization.
    Welch L; Dong X; Hewitt D; Irwin M; McCarty L; Tsai C; Baginski T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():158-167. PubMed ID: 29906677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.
    Franke AE; Danley DE; Kaczmarek FS; Hawrylik SJ; Gerard RD; Lee SE; Geoghegan KF
    Biochim Biophys Acta; 1990 Jan; 1037(1):16-23. PubMed ID: 2403813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of recombinant Interferon-α2 in E. coli periplasmic extracts by reversed-phase high-performance liquid chromatography.
    Dias PVS; Arthuso FS; Oliveira JE; Suzuki MF; Sousa JM; Ribela MTCP; Bartolini P; Soares CRJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():193-198. PubMed ID: 29179059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coli.
    Sancho E; Tonge DW; Hockney RC; Booth NA
    Eur J Biochem; 1994 Aug; 224(1):125-34. PubMed ID: 8076633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast protein separation by reversed-phase high-performance liquid chromatography on octadecylsilyl-bonded nonporous silica gel. II. Improvement in recovery of hydrophobic proteins.
    Itoh H; Nimura N; Kinoshita T; Nagae N; Nomura M
    Anal Biochem; 1991 Nov; 199(1):7-10. PubMed ID: 1666942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the primary structure of recombinant tissue plasminogen activator by reversed-phase high-performance liquid chromatographic tryptic mapping.
    Chloupek RC; Harris RJ; Leonard CK; Keck RG; Keyt BA; Spellman MW; Jones AJ; Hancock WS
    J Chromatogr; 1989 Feb; 463(2):375-96. PubMed ID: 2496137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1).
    Grebenschikov N; Sweep F; Geurts A; Andreasen P; De Witte H; Schousboe S; Heuvel J; Benraad T
    Int J Cancer; 1999 May; 81(4):598-606. PubMed ID: 10225451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.